Science Explorer Back to mapMap
Discussion
Institution · The Woodlands · United States

The US Oncology Network

In research, The US Oncology Network stands highest in Health Sciences (#6,151 of 9,902 worldwide), 2022-now. Relative to its size it is most specialised in Economics and Econometrics and Economics, Econometrics and Finance (Economics and Econometrics is 13.4× its share of world research).

usoncology.comROR OpenAlex
World rank, 2022-now
#18,617
of 22,385 · #24,774 all time
Rank in United States
#2,741
of 3,332
Research works
295
▲ 77% vs 2018-21
Citations
5.1k
17.3 per fractional work
Top-10% rate
10.3%
all institutions 10.0%
vs its own fields
0.95×
1.00× is exactly expected
Open access
28%
world 40%
International
20%
world 18%
The US Oncology Network

What is The US Oncology Network known for in research?

The fields where it stands highest, 2022-now, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorksAll time
Health SciencesDomain #6,151 of 9,902 12.3%63 #8040

Each strip is that field's whole ranked pool, with the notch where The US Oncology Network sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no average mark, because the average differs by field (from about 6% in Dentistry to 21% in Economics).

Which fields of science does The US Oncology Network work in?

In 2022-now, 58% of research at The US Oncology Network is in Health Sciences, 24% in Social Sciences. Its largest fields are Medicine (52%), Economics, Econometrics and Finance (21%), Biochemistry, Genetics and Molecular Biology (10%). It does 2.4× the world's share of Health Sciences.

Health Sciences: 71 fractional works · 57.7% of its workMedicine: 65 fractional works · 52.4% of its workOncology: 18 fractional works · 14.3% of its workPulmonary and Respiratory Medicine: 12 fractional works · 9.8% of its workPublic Health, Environmental and Occupational Health: 5 fractional works · 3.7% of its workReproductive Medicine: 4 fractional works · 3.5% of its workRadiology, Nuclear Medicine and Imaging: 3 fractional works · 2.5% of its workEpidemiology: 3 fractional works · 2.1% of its workGeriatrics and Gerontology: 3 fractional works · 2.1% of its workSurgery: 2 fractional works · 2.0% of its workHematology: 2 fractional works · 1.9% of its workGenetics: 2 fractional works · 1.8% of its workObstetrics and Gynecology: 2 fractional works · 1.5% of its workPathology and Forensic Medicine: 2 fractional works · 1.4% of its workPhysiology: 2 fractional works · 1.4% of its workFamily Practice: 1 fractional works · 0.7% of its workNeurology: 1 fractional works · 0.7% of its workPediatrics, Perinatology and Child Health: 1 fractional works · 0.5% of its workHepatology: 0 fractional works · 0.4% of its workRheumatology: 0 fractional works · 0.3% of its workOtorhinolaryngology: 0 fractional works · 0.3% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 0.3% of its workDermatology: 0 fractional works · 0.3% of its workHealth Informatics: 0 fractional works · 0.2% of its workSmaller subfields together: 1 fractional works · 0.8% of its workHealth Professions: 6 fractional works · 5.1% of its workGeneral Health Professions: 4 fractional works · 2.9% of its workHealth Information Management: 2 fractional works · 1.2% of its workEmergency Medical Services: 0 fractional works · 0.4% of its workSpeech and Hearing: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.3% of its workNursing: 0 fractional works · 0.1% of its workDentistry: 0 fractional works · 0.1% of its workSocial Sciences: 30 fractional works · 23.9% of its workEconomics, Econometrics and Finance: 26 fractional works · 21.2% of its workEconomics and Econometrics: 26 fractional works · 21.2% of its workSocial Sciences: 2 fractional works · 1.3% of its workHealth: 1 fractional works · 0.8% of its workGender Studies: 0 fractional works · 0.3% of its workSociology and Political Science: 0 fractional works · 0.2% of its workPsychology: 1 fractional works · 0.9% of its workClinical Psychology: 1 fractional works · 0.5% of its workSocial Psychology: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workBusiness, Management and Accounting: 0 fractional works · 0.3% of its workDecision Sciences: 0 fractional works · 0.1% of its workArts and Humanities: 0 fractional works · 0.1% of its workLife Sciences: 17 fractional works · 13.9% of its workBiochemistry, Genetics and Molecular Biology: 12 fractional works · 9.8% of its workMolecular Biology: 5 fractional works · 4.1% of its workCancer Research: 4 fractional works · 2.9% of its workGenetics: 3 fractional works · 2.3% of its workSmaller subfields together: 1 fractional works · 0.5% of its workImmunology and Microbiology: 4 fractional works · 3.6% of its workImmunology: 3 fractional works · 2.7% of its workApplied Microbiology and Biotechnology: 0 fractional works · 0.4% of its workMicrobiology: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.1% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 0.3% of its workPharmacology: 0 fractional works · 0.2% of its workNeuroscience: 0 fractional works · 0.2% of its workAgricultural and Biological Sciences: 0 fractional works · 0.1% of its workPhysical Sciences: 6 fractional works · 4.5% of its workComputer Science: 3 fractional works · 2.6% of its workComputer Networks and Communications: 1 fractional works · 1.0% of its workArtificial Intelligence: 1 fractional works · 0.5% of its workComputational Theory and Mathematics: 1 fractional works · 0.5% of its workInformation Systems: 1 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.2% of its workEngineering: 1 fractional works · 0.9% of its workBiomedical Engineering: 1 fractional works · 0.6% of its workSmaller subfields together: 0 fractional works · 0.4% of its workMathematics: 1 fractional works · 0.5% of its workStatistics and Probability: 1 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.0% of its workPhysics and Astronomy: 0 fractional works · 0.2% of its workRadiation: 0 fractional works · 0.2% of its workMaterials Science: 0 fractional works · 0.1% of its workEnvironmental Science: 0 fractional works · 0.1% of its workChemistry: 0 fractional works · 0.0% of its workALL ITS WORKThe US OncologyNetwork124fractional works, 2022-now
Life Sciences14%Physical Sciences4%Health Sciences58%Social Sciences24%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 22 fields, with their numbers
    1. Medicine6552.4%
    2. Health Professions65.1%
    3. Nursing00.1%
    4. Dentistry00.1%
    1. Economics, Econometrics and Finance2621.2%
    2. Social Sciences21.3%
    3. Psychology10.9%
    4. Business, Management and Accounting00.3%
    5. Decision Sciences00.1%
    6. Arts and Humanities00.1%
    1. Biochemistry, Genetics and Molecular Biology129.8%
    2. Immunology and Microbiology43.6%
    3. Pharmacology, Toxicology and Pharmaceutics00.3%
    4. Neuroscience00.2%
    5. Agricultural and Biological Sciences00.1%
    1. Computer Science32.6%
    2. Engineering10.9%
    3. Mathematics10.5%
    4. Physics and Astronomy00.2%
    5. Materials Science00.1%
    6. Environmental Science00.1%
    7. Chemistry00.0%
All of science, and how each field's share has moved since 1950: the Science domain explorer

What does The US Oncology Network specialise in?

Where its research is concentrated relative to its size: Economics and Econometrics takes 13.4× the share of its output that it takes of world research.

  1. Economics and EconometricsSubfield · 26.3 works13×
  2. Economics, Econometrics and FinanceField · 26.3 works9.9×
← less than its size predicts1×more →

Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.01× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 1.83× its world share, 12 worksBiochemistry, Geneti…Immunology and Microbiology: 3.60× its world share, 4 worksImmunology and Micro…Neuroscience: 0.11× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 0.74× its world share, 0 worksPharmacology, Toxico…Chemistry: 0.03× its world share, 0 worksChemistryComputer Science: 0.33× its world share, 3 worksComputer ScienceEngineering: 0.06× its world share, 1 worksEngineeringEnvironmental Science: 0.01× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.03× its world share, 0 worksMaterials ScienceMathematics: 0.43× its world share, 1 worksMathematicsPhysics and Astronomy: 0.10× its world share, 0 worksPhysics and AstronomyDentistry: 0.14× its world share, 0 worksDentistryHealth Professions: 1.93× its world share, 6 worksHealth ProfessionsMedicine: 2.73× its world share, 65 worksMedicineNursing: 0.18× its world share, 0 worksNursingArts and Humanities: 0.04× its world share, 0 worksArts and HumanitiesBusiness, Management and Accounting: 0.08× its world share, 0 worksBusiness, Management…Decision Sciences: 0.14× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 9.92× its world share, 26 worksEconomics, Econometr…Psychology: 0.29× its world share, 1 worksPsychologySocial Sciences: 0.10× its world share, 2 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Economics, Econometrics and Finance, 9.9×. Every wedge is a field page.

All 22 fields, with their numbers
  1. Economics, Econometrics and Finance9.92×26 works
  2. Immunology and Microbiology3.60×4 works
  3. Medicine2.73×65 works
  4. Health Professions1.93×6 works
  5. Biochemistry, Genetics and Molecular Biology1.83×12 works
  6. Pharmacology, Toxicology and Pharmaceutics0.74×0 works
  7. Mathematics0.43×1 works
  8. Computer Science0.33×3 works
  9. Psychology0.29×1 works
  10. Nursing0.18×0 works
  11. Dentistry0.14×0 works
  12. Decision Sciences0.14×0 works
  13. Neuroscience0.11×0 works
  14. Physics and Astronomy0.10×0 works
  15. Social Sciences0.10×2 works
  16. Business, Management and Accounting0.08×0 works
  17. Engineering0.06×1 works
  18. Arts and Humanities0.04×0 works
  19. Chemistry0.03×0 works
  20. Materials Science0.03×0 works
  21. Agricultural and Biological Sciences0.01×0 works
  22. Environmental Science0.01×0 works

Who are the top researchers at The US Oncology Network?

Ranked on the quality score, Nicholas J. Robert, Michael G. Teneriello and Jody S. Garey lead among researchers whose main affiliation is The US Oncology Network.

  1. 1 Nicholas J. Robert United States · #99,418 worldwide 21k citations · 315 works
  2. 2 Michael G. Teneriello United States · #404,204 worldwide 3.4k citations · 44 works
  3. 3 Jody S. Garey United States · #1,202,625 worldwide 882 citations · 63 works
  4. 4 Robyn K. Harrell United States · #1,248,169 worldwide 1.1k citations · 51 works
  5. 5 Stephen G. Divers United States · #1,369,238 worldwide 1.9k citations · 37 works
  6. 6 Lalan S. Wilfong United States · #1,517,013 worldwide 706 citations · 119 works
  7. 7 Leslie T. Busby United States · #2,011,120 worldwide 209 citations · 21 works
  8. 8 Stephanie L. Hume United States · #2,043,025 worldwide 689 citations · 23 works
  9. 9 Roy A. Beveridge United States · #2,698,993 worldwide 2.2k citations · 107 works
  10. 10 Puneeth Indurlal United States · #2,965,722 worldwide 20 citations · 63 works
All ranked researchers at The US Oncology Network

What are the most cited papers from The US Oncology Network?

The most cited paper from The US Oncology Network is "Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial" (Louis Fehrenbacher, Alexander I. Spira, Marcus D. Ballinger et al., 2016), with 2,823 citations. Next come "Talazoparib in Patients with Advanced Breast Cancer and a Germline BRCA Mutation" (2,198) and "Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer" (2,066).

Most cited papers
#PaperReleasedCitations
1 Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial Louis Fehrenbacher, Alexander I. Spira, Marcus D. Ballinger et al. · The Lancet 9 Mar 2016 2,823
2 Talazoparib in Patients with Advanced Breast Cancer and a Germline BRCA Mutation Jennifer Keating Litton, Hope S. Rugo, Johannes Ettl et al. · New England Journal of Medicine Open access 15 Aug 2018 2,198
3 Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer Gabriel N. Hortobágyi et al. · New England Journal of Medicine Open access 8 Oct 2016 2,066
4 Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast Cancer Shanu Modi et al. · New England Journal of Medicine Open access 11 Dec 2019 2,026
5 Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis Armando E. Giuliano, Karla V. Ballman, Linda Mackie McCall et al. · JAMA Open access 12 Sep 2017 1,941
All 60 most cited papers, with filters and sorting

Which keywords describe research at The US Oncology Network?

By fractional works in 2022-now, weighted toward what it does more of than the world: Cost of Care, Financial Toxicity, Chemotherapy, Clinical Trials, Quality of Life, Targeted Therapy, Cost-effectiveness Analysis and Health Utility Measures.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Cost of Care15▲ 406×1 topic
  2. Financial Toxicity15▲ 406×1 topic
  3. Chemotherapy14▲ 16×21 topics
  4. Clinical Trials13▲ 15×10 topics
  5. Quality of Life12▲ 7.0×15 topics
  6. Targeted Therapy8▲ 29×4 topics
  7. Cost-effectiveness Analysis8▲ 80×1 topic
  8. Health Utility Measures8▲ 80×1 topic
  9. Biomarkers7▲ 8.4×4 topics
  10. Breast Cancer6▲ 21×7 topics
  11. Immunotherapy6▲ 7.2×13 topics
  12. Ovarian Cancer6▲ 53×2 topics
  13. Metastasis6▲ 14×8 topics
  14. Genomic Profiling5▲ 41×2 topics
  15. Tumor Microenvironment5▲ 8.7×8 topics
  16. Precision Medicine4▲ 7.2×5 topics
  17. Clinical Practice Guidelines4▲ 6.3×10 topics
  18. Radiotherapy4▲ 8.7×10 topics
  19. Metastatic Breast Cancer4▲ 54×2 topics
  20. Cytoreductive Surgery4▲ 49×2 topics
  21. Genomic Analysis4▲ 12×2 topics
  22. Mutation Analysis4▲ 42×1 topic
  23. Tumor Models4▲ 53×1 topic
  24. Cancer Therapy4▲ 5.5×12 topics
  25. Survival Analysis4▲ 11×7 topics
  26. Treatment Guidelines4▲ 13×2 topics
  27. ALK Inhibitors3▲ 45×1 topic
  28. EGFR Mutations3▲ 45×1 topic
  29. Prognostic Factors3▲ 6.1×10 topics
  30. Ethical Considerations3▲ 7.5×5 topics
  31. Immune Checkpoint Blockade3▲ 23×1 topic
  32. PD-1 and PD-L13▲ 23×1 topic
  33. Cancer Incidence3▲ 18×4 topics
  34. Pharmaceutical Industry3▲ 68×2 topics
  35. Cell Death3▲ 10×5 topics
  36. Monoclonal Antibodies3▲ 27×3 topics
  37. Drug Development Costs3▲ 93×1 topic
  38. Elderly3▲ 9.7×3 topics
  39. Generic Drugs3▲ 93×1 topic
  40. Clinical Outcomes3▲ 11×3 topics

Which research topics does The US Oncology Network publish most on?

By volume in 2022-now: Economic and Financial Impacts of Cancer, Health Systems, Economic Evaluations, Quality of Life, Ovarian cancer diagnosis and treatment and Lung Cancer Treatments and Mutations.

Economic and Financial I…15Economic and Financial Impacts of Cancer: 15 fractional worksHealth Systems, Economic…8Health Systems, Economic Evaluations, Quality of Life: 8 fractional worksOvarian cancer diagnosis…4Ovarian cancer diagnosis and treatment: 4 fractional worksLung Cancer Treatments and Mutations: 3 fractional worksCancer Immunotherapy and Biomarkers: 3 fractional worksPharmaceutical Economics and Policy: 3 fractional worksBiosimilars and Bioanalytical Methods: 3 fractional worksCancer Genomics and Diagnostics: 2 fractional worksPARP inhibition in cancer therapy: 2 fractional worksPharmaceutical Practices and Patient Outcomes: 2 fractional works
Economics and EconometricsReproductive MedicinePulmonary and Respiratory MedicineOncology3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Economic and Financial Impacts of Cancer Economics and Econometrics 15 works
  2. 2 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 8 works
  3. 3 Ovarian cancer diagnosis and treatment Reproductive Medicine 4 works
  4. 4 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 3 works
  5. 5 Cancer Immunotherapy and Biomarkers Oncology 3 works
  6. 6 Pharmaceutical Economics and Policy Economics and Econometrics 3 works
  7. 7 Biosimilars and Bioanalytical Methods Immunology 3 works
  8. 8 Cancer Genomics and Diagnostics Cancer Research 2 works
  9. 9 PARP inhibition in cancer therapy Oncology 2 works
  10. 10 Pharmaceutical Practices and Patient Outcomes Geriatrics and Gerontology 2 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available28.4%not open71.6%

World: 40% of research is openly available.

with international co-authors20.0%domestic only80.0%

World: 18% is written across borders.

How has The US Oncology Network's research output changed?

Output in 2022-2025 was 77% higher than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is The US Oncology Network as a percentage of every work published that year, 0.00065% in 2024.

still counting0.00025%0.00050%0.00075%The US Oncology Network0.00049% in 20251990200020102020

Fractional works of The US Oncology Network over all fractional works that year. How the balance of science has shifted.

Other research institutions in The Woodlands

All research institutions in The Woodlands

Share The US Oncology Network's ranking

The US Oncology Network on Science Explorer

A card with The US Oncology Network's standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website1Each links back here and updates with every snapshot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about The US Oncology Network. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.